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Listeria monocytogenes, an uncommon foodborne pathogen, is increasingly recognized as a cause of life-
threatening disease. A marked increase in reported cases of listeriosis during 1998 motivated a retrospec-
tive nationwide survey of the infection in Israel. From 1995 to 1999, 161 cases were identified; 70 (43%)
were perinatal infections, with a fetal mortality rate of 45%. Most (74%) of the 91 nonperinatal infections
involved immunocompromised patients with malignancies, chronic liver disease, chronic renal failure, or
diabetes mellitus. The common clinical syndromes in these patients were primary bacteremia (47%) and
meningitis (28%). The crude case-fatality rate in this group was 38%, with a higher death rate in immuno-
compromised patients. 
isteria monocytogenes (Lm) is a ubiquitous pathogen in
the environment, capable of causing human and animal
infection. Although uncommon in humans, it occurs in spo-
radic and epidemic forms throughout the world (1-3); a recent
multistate outbreak was reported in the United States (4). Most
and perhaps all forms of listeriosis in humans result from food-
borne transmission (5). In its most severe form, listeriosis is an
invasive disease that affects immunocompromised patients
and has the highest case-fatality rate of foodborne illnesses (6-
10). In immunocompetent persons, it can also cause severe
disease (attributed by some investigators to ingestion of high
infective doses), as well as outbreaks of benign febrile gastro-
enteritis (11). Another form of human disease is perinatal
infection, which is associated with a high rate of fetal loss
(including full-term stillbirths)  and serious neonatal disease
(12).
Lm infection has been a reportable disease in Israel since
1993. A preliminary report from the Ministry of Health
(MOH) claimed a fivefold increase in incidence from 1996 to
1998, but the information was incomplete (13). Our study was
undertaken to delineate trends and better characterize the epi-
demiologic and clinical features of this emerging infection in
Israel and to compare these findings with those reported in
recent publications worldwide.
Material and Methods
The Israeli Survey
Of the 24 general (acute-care) hospitals in Israel, 11 are
large, with 500-1,200 beds, 8 have 300-499 beds, and 5 have
<300 beds. Information on Lm infections was collected by
contacting infectious disease specialists in each of the 19
larger hospitals. The specialists were asked to identify retro-
spectively all patients with listeriosis (as defined below) from
the period 1995-1999 in their hospitals and to complete a ques-
tionnaire on each. Questionnaires were completed from 17 of
the hospitals (11 large, 6 intermediate), and complementary
information was retrieved from the MOH passive and active
surveillance files on 4 additional hospitals (1 intermediate and
3 small). These 21 hospitals represented approximately 95%
of the total acute-care beds in Israel during the study period.
One hundred sixty-one patients with Lm infection were
identified. Clinical information was available for all patients
except five (3%: two with positive blood cultures and one with
a positive vaginal culture who were not hospitalized, and two
with positive blood cultures whose hospital charts could not be
retrieved). 
Lm isolates were identified by standard methods in the
microbiology laboratory in each medical center, then sent to
the Reference Laboratory for Listeria in Jerusalem for confir-
mation. 
Listeriosis was defined as the growth of Lm (as confirmed
at the reference laboratory) from any body site. An infection in
a pregnant woman and her fetus or neonate was considered a
single perinatal event.
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Worldwide Review
We conducted a MEDLINE search for studies describing
nonselective, population-based surveys of Lm infections in the
English language literature of the last decade (1990-2000). All
case series describing at least 15 nonperinatal, nongastroen-
teritis infections were included in the review of nonperinatal
listeriosis. All case series describing at least 15 perinatal cases
were included in the review of perinatal listeriosis.
Results
The Israeli Survey (1995-1999)
The 161 cases identified during the 5-year study period
included 91 (57%) nonperinatal and 70 (43%) perinatal infec-
tions. The average annual incidence during the study period
was 0.6/100,000 population. The marked increase in 1998
(Figure 1) was exclusively in perinatal cases; the reason for the
increase remains unclear. There were no clusters in place dur-
ing any of these years. Infection occurred throughout the year,
but more often during summer and fall, with 70% of cases
occurring from May to October (Figure 2). 
Nonperinatal Cases 
The mean age of the 87 nonperinatal cases with available
clinical information was 67 years (range 4-91), 66 (76%) were
≥ 60 years of age (Figure 3); 56 (64%) were male. Sixty-four
patients (74%) had severe immunocompromising conditions
(Table 1). Of 45 patients (52%) with malignant disease, most
had received chemotherapy, steroid therapy, or both during the
month before the Lm infection. Other immunocompromising
conditions were chronic renal failure (11 patients, 4 of whom
were on hemodialysis), chronic liver disease (10 patients,
mostly with cirrhosis), and diabetes mellitus (13 patients).
Some of these patients had additional immunocompromising
conditions (Table 1). Twenty-three patients (26%) were not
immunocompromised. Most (19 [83%] of 23) were ≥ 63 years
of age; some had concomitant conditions not considered to be
immunocompromising, including three patients with valvular
heart disease, predisposing them to endocarditis. Only four
immunocompetent patients were <60 years of age, including a
4-year-old girl and a 38-year-old man with primary bactere-
mia, a 22-year-old woman with typical pyelonephritis and Lm
cultured from blood only, and a 51-year-old man who had gas-
troenteritis and positive blood cultures (stool was not cultured
for Lm). 
Clinical syndromes in the 87 nonperinatal cases were pri-
mary bacteremia in 41 (47%), meningitis in 24 (28%), bactere-
mia with a focal infection in 18 (21%), and focal infection
without bacteremia in 4 (5%) (Table 2). Six patients with men-
ingitis had Lm isolated from both blood and cerebrospinal
fluid (CSF). Two patients with primary bacteremia had symp-
toms suggestive of meningitis (confusion, aggressiveness), but
they died shortly after admission without having a lumbar
puncture performed. 
The case-fatality rate in the nonperinatal group was 38%
(33 of 87). Twelve of the 33 deaths occurred within 48 hours
of admission or disease onset. We observed a lower mortality
rate (6 [19%] of 31) among persons who received a penicillin
(mostly ampicillin) as empiric therapy, compared with those
who received a penicillin only after culture results were
reported (9 [30%] of 30), but this difference was not statisti-
cally significant (p=0.25). The difference in death rates in
immunocompromised (28 [44%] of 64) compared with immu-
Figure 1. Number of cases of perinatal and nonperinatal Listeria mono-
cytogenes infection, Israel, 1995–1999.
Figure 2. Seasonal occurrence of Listeria monocytogenes infection,
Israel, 1995–1999.
Figure 3. Age distribution of 87 nonperinatal cases of Listeria monocy-
togenes infection by immune-status group, Israel, 1995–1999.Emerging Infectious Diseases  •  Vol. 8, No. 3, March 2002 307
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nocompetent patients (5 [22%] of 23) had borderline statistical
significance (p=0.05). There was no correlation between death
and age for the whole group; however, all five immunocompe-
tent patients who died were >80 years of age.
Perinatal Cases
Clinical information was available on 69 pregnant women
(mean age 28 years; range 21-40 years) and their offspring.
Twenty-seven pregnancies (gestational age 9-26 weeks)
resulted in intrauterine fetal death and miscarriage, one full-
term infant was stillborn, and three others (born at 26, 29, and
39 weeks) died within 24-48 hours of birth (Table 3), for a
mortality rate among offspring of 45%. Seventeen (55%) of
the 31 infected mothers whose offspring died were bacteremic.
For the other 14 mothers, Lm was isolated from other sites,
including placenta, amniotic fluid, and fetal tissue (Table 3). 
The other 38 mothers gave birth to live infants, 16 of
whom had no evidence of Lm infection. Eleven of the 16 unin-
fected infants were delivered when the mothers had active Lm
amnionitis (gestational ages 25 to 40 weeks), and 5 were deliv-
ered several weeks after the maternal infection, which
occurred at weeks 19, 21, 35, 36, and 37. Twenty-two infants
had evidence of Lm infection after birth, 18 within 48 hours of
delivery and 4 on days 4-8. Only two (11%) of the 18 infants
with early infection had meningitis, compared with all 4 with
later onset of infection.
All infected mothers had mild illness and recovered
uneventfully; none had meningitis. One mother had an under-
lying immunocompromising condition (systemic lupus erythe-
matosus).
Worldwide Review (1990-2000)
Nine case-series of nonperinatal listeriosis and five case-
series of perinatal infection matched the inclusion criteria.
These reports and our study provided 1,250 cases of
nonperinatal and 494 cases of perinatal listeriosis for analysis
(Tables 4 and 5). Nonperinatal infection constituted, on aver-
age, 65% (1,025 of 1,583) of cases among studies that sup-
plied this information (Table 4). In total, 1,250 cases of
nonperinatal infections were reviewed; information about
mortality was provided for 1,129 patients. The patients’ ages
Table 1. Immunocompromising conditions in 64 cases of non-perinatal Listeria monocytogenes infection, Israel, 1995–1999
Main underlying illness No. of cases
Additional underlying conditions
Steroids/ chemotherapy
Chronic renal 
failure Chronic liver disease Diabetes mellitus Others
Hematologic malignancy 23 19 3 2 7 8a
Solid malignancy 22 9
Chronic renal failure 8b 12 1 c
Chronic liver disease 8 1 1 2c
Diabetes mellitus 3 1
aSplenectomy (2 cases) neutropenia (5) vasculitis (1). 
bHemodialysis (4 cases). 
cSevere congestive heart failure (3 cases).
Table 2. Clinical syndromes in 87 cases of nonperinatal Listeria 
monocytogenes infection, Israel, 1995–99
Clinical syndrome
Immuno-
compromised
Immuno-
competent Total
Bacteremia without focus 34 (53%) 7 (30%) 41 (47%)
Meningitis 17a (27%) 7 (30%) 24 (28%)
Bacteremia with focus 9b (14%) 9c (39%) 18 (21%)
A focus without bacteremia 4d (6%) 0  4  (5%)
Total 64 (100%) 23 (100%) 87 (100%)
a With bacteremia (6 cases), with pneumonia (1 case).
b Endocarditis (3 cases), peritonitis (2), pneumonia (4, one with shunt infection).
c Endocarditis (3 cases), gastroenteritis (3), pyelonephritis (2), anal abscess (1).
d Peritonitis (3 cases), pleuritis (1).
Table 3. Types of infection, sources of cultures, and outcome in 69 cases of perinatal Listeria monocytogenes infection, Israel, 1995–99
Type of mother-infant infection No. of cases
Mothers’ cultures Infants’ cultures
Blood only Blood and tissue Tissue only Blood only Blood and tissue Tissue only
Uninfected mother and infected 
infant
13 (19%) 4 7 (3) 2 (2)
Infected mother and infected infant 9  (13%) 2 1 6 3 2 4 (1)
Infected mother and uninfected infant 16 (23%) 9 3 4
Fetal/neonatal death (amnionitis) 31a (45%) 4 13 14 1 1 (1)
Total 69 (100%) 54 24
aIncludes 27 intrauterine deaths with abortions, 1 stillbirth, and 3 early neonatal deaths. Numbers in parenthesis are cases of meningitis. Tissue denotes any material that is not blood, 
such as cerebrospinal fluid, placenta, and amniotic fluid.RESEARCH
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ranged from <1 year to >90 years, but most were >60 years of
age. The mean ages in the different series ranged from 50 to 67
years; 60% were male. Annual incidence rate varied widely
(i.e., 0.1-1.1 per 105), not only between countries but also
between consecutive years in the same setting. Most authors
also described seasonal variation, with a peak incidence in
summer possibly related to seasonal consumption of specific
food products (8) or to more frequent breakdowns in food han-
dling in higher temperatures.
Most (74%) of the persons affected in the reported cases
(Table 4) were immunocompromised. Malignancy, chemother-
apy, steroid therapy, organ transplantation, alcoholism, liver
disease, renal insufficiency, and diabetes mellitus were most
commonly reported, with few cases of acquired immunodefi-
ciency syndrome.
With regard to clinical syndromes, the most common
(47%) site of infection was the central nervous system (CNS)
(Table 4), frequently associated with bacteremia. An addi-
tional 48% of patients were bacteremic without CNS involve-
ment.
Perinatal infection constituted 34% (470 of 1,378) of cases
among studies that supplied this information (Table 5). In
total, 494 cases of perinatal infections were reviewed. Infec-
tion during the first two trimesters of pregnancy was almost
invariably fatal to the fetus. One hundred six (21%) of the 494
pregnancies reviewed here resulted in intrauterine death. 
Two hundred seventy-eight (56%) live-born infants had
neonatal listeriosis and survived. Most of this neonatal infec-
tion was of early onset (209 cases), but the definition of early
onset varied (from #5 to #7 days), and information concerning
day of onset was incomplete in some series (Table 5). Almost
all the late-onset infections (69 cases) were of the CNS. An
additional 61 infants (12%) with neonatal listeriosis died from
the infection in the postnatal period, for an overall intrauterine
and postnatal mortality rate of 34% (167 of 494). In 49 (10%)
of the affected pregnancies, the infant was born alive and with-
Table 4. Characteristics of nonperinatal listeriosis from 10 recently reported series
Characteristic
First author, year (ref)
Total or
average
McLauchlin, 
1990 (8)
Gellin, 
1991 (6)
Cherubin, 
1991 (14)
Skogberg, 
1992 (15)
Nolla-Salas, 
1993 (16)
Jones, 
1994 (17)
Paul, 1994 
(18)
Bula, 1995 
(10)
Goulet, 
1996 (9)
Siegman-
Igra, 2001 
(present 
study)
Country and 
scope 
England, 
national
USA, six 
areas
USA, four 
centers
Finland, 
Helsinki
Spain, 
Barcelona
England, 
Bristol
Australia,  
Sydney
Switzerland, 
western part
France, 
national
Israel, 
national
Worldwide
Study period 1967-1985 1986 1982-1999 1971-1989 1990 1983-
1992
1983-1992 1983-1997 1992 1995-1999 1967-1999
Total no. of 
cases
722 246 119 74 31 29 84 122 225a 156 1,808
Nonperinatal 
cases 
(% of total)
474 (66%) 179 (73%) 54 (45%)  58 (78%) 29 (94%) 16 (55%) 71 (85%) 57 (47%) 225 (NA) 87 (56%) 1,025/1583 (65%)
1,025+225=1,250
Mean age 
(range) 
(years)
59 (1-97) NA (<1-95) NA 50 (29-66) 58 (17-89) 60 (1-95) 39% (>60) 66 (31-96) 65 (1-101) 67 (4-91) 50-67
Male gender 265 (58%) 101 (56%) NA NA 24 (77%) 9 (56%) NA 33 (58%) 135 (62%) 56 (64%) 623 (60%)
Peak season  Autumn and 
spring 
Late spring 
to fall
May-Aug NA 39% in July-
Sept
76% in 
July-Dec
NA NA NA 70% in
 May-Oct
Summer 
and fall
Annual 
incidenceb
NA 0.7 NA 0.09 - 0.65 1.1 0.35 0.3 NA NA 0.6 0.1-1.1
Immunocom-
promised
261/337 
(77%)
NA 53/
54(98%)
47/
58(81%)
24/29 
(83%)
13/16 
(81%)
59/71 
(83%)
25/57 
(42%)
159/
225(71%)
64/87 
(74%)
705/934 
(74%)
CNS infec-
tion
268/474 
(57%)
55/179 
(31%)
19/54 
(35%)
29/58 
(50%)
9/31 
(29%)
6/16 
(37%)
29/71 
(41%)
45/57 
(79%)
110/224
(49%)
24/87 
(28%)
594/1,251 
(47%)
Bacteremia + 
focusc 
183/474 
(39%)
119/179 
(66%)
35/54 
(65%)
24/58 
(41%)
20/31 
(65%)
10/16 
(73%)
40/71 
(56%)
12/57 
(21%)
97/224 
(43%)
59/87 
(68%)
599/1,251 
(48%)
Focal dis-
ease onlyd
9/474 
(5%)
5/179 
(3%)
-5 / 5 8  
(8%)
2/31 
(6%)
- 2/71 (3%) - 17/224 
(8%)
 4/87 
(5%)
44/1,124 
(4%)
Mortality 164/371 
(44%)
63/
179(35%)
17/
54(31%)
15/
58(26%)
16/31 
(52%)
6/16 
(37%)
27/71 
(38%)
18/57 
(32%)
54/225 
(24%)
33/87 
(38%)
413/1,149 
(36%)
aIncludes nonperinatal cases only. 
bEstimated annual incidence per 105 population. 
cBacteremia with or without a non-CNS focus of infection (e.g., pneumonia, endocarditis, urinary tract infection, prostatitis, peritonitis, gastroenteritis, rectal abscess, osteomyelitis, and 
cellulitis).
dFor example, peritonitis, pleuritis, arthritis, pericarditis, cholecystitis, appendicitis, and cellulitis.
NA= not available; CNS= central nervous systemEmerging Infectious Diseases  •  Vol. 8, No. 3, March 2002 309
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out evidence of listeriosis. 
Discussion
Ingestion of Lm is a very common occurrence (1,2) since it
has been isolated from many food products in Israel (unpub.
data, MOH) as well as in many countries worldwide. Develop-
ment of invasive disease secondary to Lm ingestion is deter-
mined primarily by the integrity of the immune system of the
host (predominantly cell-mediated immune defects) and possi-
bly also by inoculum size (11). The organism crosses the
mucosal barrier of the intestine and invades the bloodstream. It
may disseminate to any organ, but it has a clear predilection
for the placenta and CNS, thereby determining the main clini-
cal syndromes.
The case-fatality rate in the collected data on perinatal
infection was 36% (413 of 1,149 patients for whom this infor-
mation was available). This high mortality reflects both the
severity of Lm infection and the seriousness of the underlying
conditions. Higher mortality rates were correlated with older
age, presence of CNS infection, and immunodeficiency
(5,6,8,15,21). One study reported that deaths in immunocom-
petent patients occurred exclusively in the elderly (9), a find-
ing that correlates well with our observations.
An unexpected observation in our study was the occur-
rence of hospital-acquired listeriosis in adults. The presumed
hospital acquisition occurred on day 3-67 of hospital stay in 59
(16%) of 369 cases with relevant information, as reported in
four studies, including ours (9,16,18). All patients acquiring
listeriosis in the hospital (except one) were immunocompro-
mised. No clustering of cases in time or place occurred, and no
case had an obvious source for nosocomial acquisition of Lm.
Because the incubation period of listeriosis is long (11-70
days) and fecal carriage not uncommon (5%-10%) (1,2), colo-
nization could have been acquired before hospitalization and
infection developed in the hospital, possibly even triggered by
increased immunosuppression. Another possible explanation
is consumption of contaminated food brought in from sources
outside the hospital, but this could not be documented. We
found only one description of a hospital outbreak of Lm
among adults (three cases secondary to an index one), but the
method of transmission was not established (22). Hospital
transmission among neonates in nurseries was thought to
occur more frequently (24%) (12) and was described by sev-
eral investigators (18,23,24).
Table 5. Characteristics of perinatal listeriosis from six recently reported series 
Characteristic
First author, year (ref)
Total or average
McLauchlin, 
1990 (12)
Gellin, 1991 
(6)
Cherubin, 
1991 (14)
Craig, 1996 
(19)
Nolla-Salas, 
1998 (20)
Siegman-Igra, 
2001 (present 
study)
Country and region England, 
national
USA, six 
areas
USA, four 
centers
Australia, 
Melbourne
Spain, 
Barcelona
Israel, 
national
Worldwide
Study period 1967-1985 1986 1982-1999 1983-1994 1990-1996 1995-1999 1967-1999
Total no. of cases 722 246 119 24a 135 156 1,400
Perinatal infection (% of total) 248 (34%) 67 (27%) 65 (55%) 24 (NA) 21 (16%) 69 (44%) 470/1,378 (34%)
470+24=494
Estimated incidence per 104 births NA 0.8-2.4 NA 2 0-4.1 1.4 0.6-4.1
Average maternal age (range) 
(years)
NA 26 (17-35) NA NA (18-39) 30 (26-34) 28 (21-40) NA (26-30)
Early neonatal infection and 
survival
114b (46%)  31 (46%) 20 (31%)  14c (58%) 11 (52%) 19 (28%) 209/494 (42%)
Late neonatal infection and survival 36d (15%) 8e (12%) 21(32%) 1d (5%) 3d (4%) 69/494 (14%)
Infected mother and uninfected 
infant
9 (4%) 13 (19%) 2 (3%) 4 (17%) 5 (23%) 16 (23%) 49/494 (10%)
Intrauterine death 42 (17%) 14 (21%) 15 (23%) 4 (17%) 3 (14%) 28 (41%) 106/494 (21%)
Postnatal death 47 (19%) 1 (1%) 7 (11%) 2 (8%) 1 (5%) 3 (4%) 61/494 (12%)
Gestational age at abortion (weeks) 12-28 11-30 NA 18-29 10-27 9-26 9-29 
Immunocompromised mothers 5  1  1  1  8f
aIncludes only perinatal cases. 
bIncluding 29 with unknown time of onset. 
cNo differentiation between early and late neonatal infection. 
d>5 days. 
e>7 days. 
f2 diabetes mellitus, 2 renal transplant, 2 systemic lupus erythematosus, 1 Crohn disease and steroids, 1 HIV infection.
NA= not availableRESEARCH
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Among perinatal infections, we report the highest case-
fatality rate (45%). This observation could be related to the
frequency of taking cultures from aborted tissues. The diagno-
sis of Lm can easily be missed if cultures are not routinely
taken from aborted fetal tissues or if blood (and other) cultures
are not obtained from febrile pregnant women. The great vari-
ability in incidence rates and other epidemiologic features
between studies and among medical centers within studies
suggests that many cases escaped diagnosis. 
Concerning the mothers, all authors described a mild
febrile “influenzalike” illness, without maternal deaths. Only
one of the 494 mothers had meningoencephalitis with Lm iso-
lated from the cerebrospinal fluid, but underlying condition or
maternal and fetal outcomes were not reported (12). Eight
mothers (<2%) were immunocompromised (Table 5), but no
comparable data are available on the prevalence of these con-
ditions among pregnant women in general. 
In conclusion, listeriosis is an emerging zoonosis that con-
stitutes a life-threatening disease for human fetuses and neo-
nates, the elderly, and patients with certain predisposing
conditions. Documented cases may not represent the true inci-
dence in the community, especially with regard to perinatal
infection. Fetal and maternal cultures should be obtained in
every case of spontaneous abortion or stillbirth, to ensure
proper diagnosis. Empiric ampicillin therapy should be
included in the treatment of neonatal meningitis, sepsis, or
meningitis in the elderly and immunocompromised patients
and in febrile pregnant women without a source of infection. 
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